background image

Paid Clinical Trials Dallas

Discover 1,872 paid clinical trials in Dallas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Fort Worth, Norman, Austin, Tomballshow 42 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Dallas, Frisco, McKinney, Corsicanashow 68 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting
PHASE3

Sponsor:

GB002, Inc.

Location:

Dallas, Plano, Oklahoma City, Houstonshow 47 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism

Recruiting

Sponsor:

The University of Texas at Dallas

Location:

Richardson

Code:

NCT06596226

Conditions

Autism

Eligibility Criteria

Sex: All

Age: 16 - 30

Healthy Volunteers: Not accepted

Interventions

Pathways Parent Mediated Intervention

Pathways Parent Mediated Intervention without Mutual Gaze

Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting
PHASE1
PHASE2

Sponsor:

Ocugen

Location:

Dallas, Bellaire, Jackson, Phoenixshow 2 more

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

Recruiting

Sponsor:

CAGE Bio Inc.

Location:

Fort Worth

Code:

NCT05202366

Conditions

Fungal Infection

Onychomycosis

Tinea Unguium

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

CGB-400 Topical Gel

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Recruiting
PHASE1
PHASE2

Sponsor:

OncoResponse, Inc.

Location:

Irving, Austin, San Antonio, Fairfax

Code:

NCT06090266

Conditions

Cancer

Tumor, Solid

Malignant Neoplasm

Metastatic Cancer

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OR502

Cemiplimab

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Recruiting
PHASE1
PHASE2

Sponsor:

Jazz Pharmaceuticals

Location:

Dallas, Houston, Memphis, Cincinnatishow 9 more

Code:

NCT05734066

Conditions

Refractory Ewing Sarcoma

Relapsed Ewing Sarcoma

Ewing Sarcoma

Eligibility Criteria

Sex: All

Age: 2 - 30

Healthy Volunteers: Not accepted

Interventions

Lurbinectedin

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Lewisville, Frisco, Oklahoma City, Fort Smithshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Dallas, Plano, Forney, Lewisvilleshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting
PHASE1
PHASE2

Sponsor:

Amgen

Location:

Dallas, Irving, Tyler, Houstonshow 8 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Dallas, DeSoto, Kingwood, Boerneshow 64 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas